Palvella Therapeutics, Inc share price logo

Palvella Therapeutics, Inc Share Price

NASDAQ: PVLA

Small Cap

$129.39

+0.39

(+0.30%)

as on

Palvella Therapeutics, Inc Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $127.20
    $131.76
    downward going graph

    1.69%

    Downside

    1.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $20.20
    $151.18
    downward going graph

    84.39%

    Downside

    16.84%

    Upside

    downward going graph

Palvella Therapeutics, Inc share price movements today

Previous Close
$129.00
Open
$129.19
Volume
231.9K
Day's Low - High
$127.20 - $131.76
52 Week Low - High
$20.20 - $151.18

Palvella Therapeutics, Inc Historical Returns

1 Month Return
+ 6.12 %
3 Month Return
+ 24.57 %
1 Year Return
+ 441.29 %
3 Year Return
0 %
5 Year Return
0 %

Palvella Therapeutics, Inc Stock Fundamentals & Key Indicators

Check Palvella Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-5.14

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-92.10%

Palvella Therapeutics, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palvella Therapeutics, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Palvella Therapeutics, Inc image
Palvella Therapeutics, Inc
NA$1.8BNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$45.0B144.14%145.058.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.0B100.94%28.9832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA123.515.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B52.74%17.9931.41%

Stock Returns calculator for Palvella Therapeutics, Inc Stock including INR - Dollar returns

The Palvella Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Palvella Therapeutics, Inc investment value today

Current value as on today

₹5,84,898

Returns

₹4,84,898

(+484.9%)

Returns from Palvella Therapeutics, Inc Stock

₹4,40,702 (+440.7%)

Dollar Impact

₹44,196 (+44.2%)

Palvella Therapeutics, Inc Stock’s Investor Sentiment and Interest

Search interest for Palvella Therapeutics, Inc Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-71% versus previous 30 day period

Palvella Therapeutics, Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
19
1
0
-
-
-
-
-
-
-
Gross Profit
18
1
-
-
-
-
-
-
-
-
Operating Income
3
-5
-1
-2
-5
-4
-7
-9
-10
-11
EBITDA
-10
-4
-1
-3
-2
-4
-6
-8
0
-10
Interest Expense
-
-
0
1
1
1
1
1
1
1
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-10
-4
-2
-4
-6
-3
-8
-9
-11
-12
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-10
-4
-2
-4
-6
-3
-8
-9
-11
-12
Net Profit Margin
-55.08%
-352.89%
-4784.91%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Palvella Therapeutics, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
25
29
46
29
31
25
-
-
-
Gross Profit
-
-
-
-
29
29
23
-
-
-
Operating Income
-22
-14
-30
-27
-33
-51
-43
-11
-14
-38
EBITDA
-22
-16
-26
-24
-34
-43
-30
18
-13
-35
Interest Expense
-
-
-
-
-
-
-
-
4
5
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-22
-16
-27
-25
-37
-45
-33
18
-17
-41
Income Tax Expense
0
1
0
-
0
-
-1
-
-
-
Net Income
-22
-17
-26
-25
-37
-45
-33
18
-17
-41
Net Profit Margin
-391.00%
-69.82%
-91.93%
-55.03%
-126.97%
-145.58%
-128.47%
0.00%
0.00%
0.00%

Palvella Therapeutics, Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
-2
-4
-6
-3
-8
-9
-11
-7
Operating Cash Flow
-19
-1
-1
-2
-5
-6
-5
-7
-4
Investing Cash Flow
3
-
-
-
-3
-
-
-
-
Financing Cash Flow
0
-
9
2
74
-1
0
0
0
Change in Cash
-15
-1
0
0
69
56
-5
-6
-5

Palvella Therapeutics, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-45
-27
18
-17
-41
Operating Cash Flow
-7
-14
-13
-10
-25
Investing Cash Flow
0
-21
-
-
-
Financing Cash Flow
59
9
5
87
0
Change in Cash
47
-5
-8
76
-25

Insights on Palvella Therapeutics, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PVLA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, PVLA stock has moved up by 69.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PVLA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -3.95M → -12.71M (in $), with an average decrease of 38.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarter

About Palvella Therapeutics, Inc

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.
OrganisationPalvella Therapeutics, Inc
Headquarters353 W. Lancaster Avenue, Wayne, PA, United States, 19087
IndustryBiotechnology
CEOMr. Wesley H. Kaupinen
E-voting on sharesClick here to vote

Key Management of Palvella Therapeutics, Inc

Name

Title

Ms. Bohan Wei

Vice President of Corporate Development & New Product Planning

Ms. Emily Cook

Senior Vice President of Clinical Operations

Mr. Jason Burdette

SVP of CMC & Technical Operations

Ms. Ashley Kline

Chief Commercial Officer

Dr. David W. Osborne Ph.D.

Chief Innovation Officer

Mr. Wesley H. Kaupinen

Founder, President, CEO & Director

Ms. Kathleen Goin

Chief Operating Officer

Mr. Kent Taylor

Senior Vice President of Sales

Dr. Jeffrey Martini Ph.D.

Chief Scientific Officer

Mr. Matthew E. Korenberg

CFO & Treasurer

FAQs

What is Palvella Therapeutics, Inc share price today?

Palvella Therapeutics, Inc share price today is $129.39 as on at the close of the market. Palvella Therapeutics, Inc share today touched a day high of $131.76 and a low of $127.2.

What is the 52 week high and 52 week low for Palvella Therapeutics, Inc share?

Palvella Therapeutics, Inc share touched a 52 week high of $151.18 on and a 52 week low of $20.2 on . Palvella Therapeutics, Inc stock price today i.e. is closed at $129.39,which is 14.41% down from its 52 week high and 540.54% up from its 52 week low.

What is Palvella Therapeutics, Inc's market capitalisation today?

Palvella Therapeutics, Inc market capitalisation is $0.00T as on .

How to invest in Palvella Therapeutics, Inc Stock (PVLA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Palvella Therapeutics, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Palvella Therapeutics, Inc Shares that will get you 0.0116 shares as per Palvella Therapeutics, Inc share price of $129.39 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Palvella Therapeutics, Inc Stock (PVLA) from India?

Indian investors can start investing in Palvella Therapeutics, Inc (PVLA) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Palvella Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Palvella Therapeutics, Inc share’s latest price of $129.39 as on April 15, 2026 at 1:29 am IST, you will get 0.0773 shares of Palvella Therapeutics, Inc. Learn more about fractional shares .